Alzheimer's Disease Resources for Families and Health Professionals
NEW! The Assessment of Cognitive Complaints Toolkit for Alzheimer's Disease (PDF, 2.19 MB)
NEW! The Assessment of Cognitive Complaints Toolkit for Alzehimer's Disease Instruction Manual (PDF, 2 MB)
The Assessment of Cognitive Complaints Toolkit for Alzheimer's Disease (ACCT-AD) is composed of two components, the instruction manual and the complete toolkit. The ACCT-AD is designed to provide primary care providers with the tools necessary to recognize normal cognition, diagnose Alzheimer's disease, and identify other cognitive problems requiring specialty referral. It differs from many other toolkits that have been published for this purpose because many of the other toolkits focus on diagnosis of dementia, but provide limited guidance on identifying the specific neurodegenerative disorder. Disclaimer: This toolkit was developed for use by healthcare providers and should not be used by non-professionals to diagnose or determine significance of cognitive complaints without the involvement of an experienced and knowledgeable professional. Interpretation of the answers to these questions requires expert knowledge and must be done in the context of knowing the general health history. If, in reviewing this toolkit, you identify concerning problems, you should discuss it with your physician. Similarly, if you have concerns about your memory or cognition, you should discuss them with your physician even if reviewing this toolkit has led you to believe they are not worrisome. Toolkit development was funded by the State of California General Fund (Senate Bill 833 sponsored by the Alzheimer's Association in 2016).
2017 Guidelines for Alzheimer's Disease Management (PDF, 66.6 KB)
This 2017 Update Reflects New Evidence, Improved Practice and Changes in Law — This is the 4th edition of the California Alzheimer's Clinical Care Guideline, first published in 1998 and revised in 2002 and 2008. The 2017 update specified in statute (SB 613, Chapter 577, 2015) addresses changes in scientific evidence, clinical practice, and state and federal law.
Alzheimer's Disease Program Report to the Legislature, March 2018 (PDF, 148 KB)
The required legislative report (SB 613, Chapter 577, 2015) includes an overview of the working group meetings that were held, an overview of the previous 2008 Guideline, along with recommendations from the working group that developed the Guideline. The current 2017 Guideline aligns with current legislation prescribed by SB 613 and is designed to improve Alzheimer's disease management.
Geriatric Depression and Dementia Scale Mobile Application
The Geriatric Depression
and Dementia Scale (GDDS) application automates screening patients for
depressive symptoms and identifying warning signs for cognitive impairment and
dementia in clinical settings. The GDDS includes the 15-item version of the
Geriatric Depression Scale and pairs it with a 15-item evaluation that helps to
identify dementia warning signs. The GDDS performs these tasks in 10 different
languages (English, Arabic, Armenian, Chinese, Farsi, Korean, Russian, Spanish,
Tagalog, and Vietnamese) and also provides spoken prompts for patients that
have vision impairments or those that struggle with the written word. It was
developed by faculty at Stanford University School of Medicine and the VA Palo
Alto Health Care System with funding made available by the California
Department of Public Health.
Medication and Treatment Options for Persons with Cognitive Impairment
University of San Francisco's Memory and Aging Center, which also operates the California Alzheimer's Disease Center, provides an in-depth overview of medications for people with cognitive impairment. It is generally a good idea to try nondrug interventions before turning to medications, but sometimes medications are necessary.
Alzheimer's Greater Los Angeles
Alzheimer's Orange County
Alzheimer's San Diego
California Caregiver Resource Centers
Alzheimer's Association (National)
National Institute on Aging
Alzheimer's Disease International